Eric M. Green has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 2015. He holds an MBA from Olin Business School and a Bachelor's in Chemistry. Before joining West, he led the Research Markets division at...

Eric M. Green has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 2015. He holds an MBA from Olin Business School and a Bachelor's in Chemistry. Before joining West, he led the Research Markets division at Sigma-Aldrich and held various roles there since 1993. Under his leadership, West has seen significant growth, particularly in performance metrics like EPS and operating cash flow. In 2023, Green’s compensation summed up to nearly $10 million, which is linked closely to the company’s performance. Notably, he has made substantial stock movements, with his holding reaching over $40 million at its peak in 2021. His focus on aligning executive pay with company performance showcases a commitment to not just short-term gains but sustainable growth for the future of West. Outside of work, he engages with the community, serving on the Board of Directors for the World Trade Center-St. Louis and the Board of Trustees for the St. Louis Children’s Hospital Foundation.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other West Pharmaceutical Services CEOs

W

Eric M. Green

CEO of West Pharmaceutical Services

Education

MBA from Olin Business School, Washington University in St. Louis; Bachelor's in Chemistry from Bethel University

Sector of Economy

Healthcare

Born

January 1, 1971 - 54 years ago

CEO of West Pharmaceutical Services for

9 years 11 months (Apr 2015 - Present)

Previous Experience

Executive Vice President and President of the Research Markets business unit at Sigma-Aldrich Corporation

Rivals

Competitors/colleagues of Eric M. Green

C

Kevin J. McNamara

CEO of Chemed

2023 Compensation

Stock

$1.26M

Salary

$1.60M

Bonus

$2.92M

Other

$1.31M

Total Holdings

$62.25M

E

Mark J. Tarr

CEO of Encompass Health Corporation

2023 Compensation

Stock

$3.28M

Salary

$1.05M

Bonus

$0.00

Other

$66.92K

Total Holdings

$51.02M

Holdings

See how much did Eric M. Green make over time.

Eric M. Green's insider trading history shows he peaked at over $40 million in holdings in 2021, marking a notable rise from around $9.87 million in 2019. Throughout 2021 and 2022, his holdings fluctuated, maintaining over $30 million for much...

Eric M. Green's insider trading history shows he peaked at over $40 million in holdings in 2021, marking a notable rise from around $9.87 million in 2019. Throughout 2021 and 2022, his holdings fluctuated, maintaining over $30 million for much of 2022. However, he saw a decrease in early 2023, with his holdings dropping back to around $30 million. By late 2023, his holdings were reported around $90 million, indicating a strong recovery. These fluctuations reflect the market performance of West Pharmaceutical Services and highlight his potential as a significant shareholder when the company's performance aligns with his vision for growth.

Total Stock Sold

$139.16M

WST

$139.16M

402,864 WST shares

What if they kept their stock?

If Eric M. Green didn't sell their stock, today they would have:
Extra WST402,864 shares worth $66.39M.
This is -52.29% and $72.77M less than what they got when they sold the stock.

Charitable Transactions

WST

15,650 shares

WST

Recent Charitable Transactions

WST

$3.36M

WST at $343.00/share

Dec 6, 2023

Charity

WST

$1.00M

WST at $371.47/share

Dec 31, 2022

Charity

WST

$1.02M

WST at $325.00/share

Dec 31, 2021

Charity

Insider Trading

See recent insider trades of Eric M. Green.

WST

$9.36M

WST at $304.71/share

Aug 6, 2024

Sale

WST

$24.20M

WST at $366.65/share

May 7, 2024

Sale

WST

$24.20M

WST at $366.65/share

May 7, 2024

Sale

WST

$23.08M

WST at $359.85/share

Feb 27, 2024

Sale

WST

6,567 shares

WST

Feb 20, 2024

Received

WST

$3.36M

WST at $343.00/share

Dec 6, 2023

Charity

WST

$17.38M

WST at $394.91/share

Aug 8, 2023

Sale

WST

$16.01M

WST at $363.81/share

May 9, 2023

Sale

WST

$14.19M

WST at $322.47/share

Mar 7, 2023

Sale

WST

$4.53M

WST at $306.68/share

Feb 21, 2023

Received

Compensation History

See how much did Eric M. Green make over time.

In 2023, Eric M. Green's total compensation reached nearly $10 million, primarily driven by his salary and a substantial bonus linked to West Pharmaceutical's performance metrics. His base salary saw a slight increase to approximately $1.14 million, from $1.11 million in 2022. The performance bonus, which he earned at 121.5% of target, was about $1.67 million, showcasing his successful leadership amid strong financial results. Eric's compensation demonstrates an alignment with company goals, focusing on increasing shareholder value while ensuring that executive pay remains competitive to attract and retain talent. This philosophy promotes a pay-for-performance culture within the organization. He has emphasized that both short-term results and long-term strategies are essential to maintaining West's growth trajectory.

Year

2023

Total Compensation

$2.90M

Salary

$1.14M

Board Justification

The compensation philosophy is designed to align executive pay with company performance, focusing on both short-term and long-term goals, ensuring competitive pay to attract and retain talent.

Bonus

$1.67M

Board Justification

The bonus is based on the Annual Incentive Plan (AIP) performance metrics, which include EPS, net sales, and operating cash flow, and was paid out at 121.5% of target for 2023.

Other

$92.48K

Board Justification

Other compensation includes contributions to retirement plans and life insurance premiums.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards vested in 2023 as the focus is on the performance share units (PSUs) and stock options that are not included in the total compensation calculation.

Performance Metrics

Performance metrics for 2023 included EPS, consolidated net sales, operating cash flow, and consolidated gross profit.

Other West Pharmaceutical Services CEOs

Here are other CEOs of West Pharmaceutical Services

Donald E. Morel, Jr., Ph.D.

Ex-CEO of West Pharmaceutical Services

June 2005 - July 2015